Exhibit and Poster Hall Hours
Monday, February 23 · 3:15 pm - 6:45 pm
Tuesday, February 24 · 10:15 am - 3:45 pm
Wednesday, February 25 · Closed

IBC開催のAsia TIDES 2009は、処方からデリバリー規制最新動向を含め、オリゴヌクレオチドおよびペプチドによる治療戦略の開発について世界のベストプラクティスを日本に紹介する唯一のイベントです。

日本の製薬企業や学術機関の研究者らは、オリゴヌクレオチドおよびペプチド治療という将来性の高い新たな分野に大変関心を寄せています。特にsiRNAやmRNA、アプタマーおよび関連分子といった注目の分野に関心が高まっています。これは世界中の開発最新動向を日本に紹介するイベントです。ハイライトは分析および生物分析技術、研究用のRNA/DNAを商品化できる規模に拡大するための合成と精製についての講義です。

メインカンファレンスではこの分野におけるデリバリーと処方、主な課題について焦点を当て、最適化とCMC開発を含めた世界の前治験および治験中化合物に関するケーススタディをまとめて紹介し、世界の規制動向と市場環境、パートナーシップなどについても取り扱います。

Keynote Presentations
	Yoshikazu Nakamura, Ph.D. University of Tokyo; Ribomic Japan		Akira Yamada, Ph.D. Kurume University Research Center for Innovative Cancer Therapy Japan
	Junichi Yano, Ph.D. Nippon Shinyaku Co., Ltd. Japan		Takumi Kawabe, M.D., Ph.D. CanBas Japan
Featured Presentations
	Larry Gold, Ph.D. SomaLogic, Inc. USA		Rachel Meyers, Ph.D. Alnylam Pharmaceuticals USA

"AsiaTIDES: A first-of-its-kind meeting in Asia providing valuable insight into this niche area."
- Philip R. Oldfield, Ph.D., Scientific Director, Immunochemistry, Laboratory Sciences, Charles River Laboratories PCS-MTL, Canada

"The concentration of key industry players at TIDES is fantastic; the event is tremendously useful… Almost all the important decision-makers attended TIDES 2008."
- Simon May, Ph.D., Global Director, Business-to-Business Sales, Life Science Research, Thermo Fisher Scientific, United Kingdom

Attendees Praise the U.S. TIDES Conference

"The conference brought nearly all the experts in oligonucleotide therapeutics area under one roof, which made for an educational and entertaining meeting."
- Sumit Lutara, Senior Scientist, Pfizer, Inc, USA

"TIDES conferences in Europe and USA are always great places to learn about all the different aspects of oligonucleotide manufacturing, new diagnostic and therapeutic applications and ideal venues to network with colleagues and customers. I am excited that this great event now also starts in Asia."
- Peter Haima, Ph.D., Manager IVD Services, Eurogentec S.A., Belgium

"I have participated in TIDES since its inception and find it to be by far the most useful meeting in the field, for both the latest updates on drug development and regulatory issues, and also for networking with industry leaders."
- Michael S. Verlander, D. Phil., Executive Vice President, PolyPeptide Laboratories, Inc., USA and India

About the Organizers
This event is brought to you by the organizers of TIDES Peptide and Oligonucleotide® Technology and Product Development and EuroTIDES conferences, as well as Drug Discovery and Development of Innovative Therapeutics World Congress in Boston and Japan, IBC Life Sciences, an informa business. Other informa businesses include: Datamonitor, MedTRACK, SCRIP and Pharmaprojects. www.IBCLifeSciences.com and www.informa.com

Conference Language
The conference will be conducted in English without translation.